Muscatine, Iowa, United States Stanley Family Foundation appeared to be the Corporate Investor, which was created in 1956. The leading representative office of defined Corporate Investor is situated in the Muscatine. The fund was located in North America if to be more exact in United States.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Stanley Family Foundation, startups are often financed by MVM Life Science Partners, Novartis Venture Fund, Clarus Ventures. The meaningful sponsors for the fund in investment in the same round are Takeda Ventures, Clarus Ventures. In the next rounds fund is usually obtained by Teva Pharmaceutical Industries.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Heptares Therapeutics. Among the most successful fund investment fields, there are Biotechnology, Pharmaceutical.
The increased amount of exits for fund were in 2015. The top activity for fund was in 2013. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
Related Funds
| Fund Name | Location |
| BAIC Group | Beijing, Beijing, China |
| Bio/Med Investor Network | Atlanta, Georgia, United States |
| Cambium Grove Capital | - |
| Campus Founders Fund | Salt Lake City, United States, Utah |
| Caribou Property | - |
| Conviction Investment Partners | Newcastle upon Tyne, North East, United Kingdom |
| Digital China | Beijing, China, Haidian |
| DOT Capital | New York, New York, United States |
| DoubleRock | California, Menlo Park, United States |
| Health Care Service Corporation | Chicago, Illinois, United States |
| Heyong Touzi | China, Fujian, Xiamen |
| Hitachi Global Life Solutions | Japan, Shibuya |
| Inventures Group | California, Palo Alto, United States |
| Jollychic | China, Hangzhou, Zhejiang |
| Kateeva | California, Newark, United States |
| Lodestar Ventures | California, San Francisco, United States |
| Onventures | Columbus, Ohio, United States |
| President International Development Corporation | Taipei, Taiwan |
| SB Media Holdings | Japan, Tokyo |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Heptares Therapeutics | $21M | 27 Jun 2013 | England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Heptares Therapeutics | $21M | 27 Jun 2013 | England |
